Valuation: G MEDPAR

Market Cap 723K 632K 583K 540K 1.02M 69.01M 1.04M 6.98M 2.74M 33.89M 2.71M 2.66M 117M P/E 2021
-1.29x
P/E 2022 -0.17x
Enterprise Value 2.52M 2.2M 2.03M 1.88M 3.57M 241M 3.63M 24.35M 9.54M 118M 9.46M 9.26M 409M EV / Sales 2021
4.92x
EV / Sales 2022 1.15x
Free-Float
-
Yield 2021 *
-
Yield 2022 -
1 day+9,900.00%
Current year-50.00%
1 week 0
Extreme 0.0001
0
1 month 0
Extreme 0
0
Current year 0
Extreme 0
0
1 year 0
Extreme 0
0.03
3 years 0
Extreme 0
0.36
5 years 0
Extreme 0
235.9
10 years 0
Extreme 0
235.9
Manager TitleAgeSince
Chief Executive Officer 75 02/10/2014
Director of Finance/CFO 46 30/07/2022
Chief Tech/Sci/R&D Officer 56 30/11/2017
Director TitleAgeSince
Director/Board Member 75 02/10/2014
Chairman 72 20/08/2014
Director/Board Member 76 23/02/2017
Date Insider Type Main position Quantity % Market Cap.
30/03/23
AWM Investment Co., Inc.
OtherCompany 1,437,500 73.2011%
30/03/23
AWM Investment Co., Inc.
SellCompany 737,500 37.5554%

Financials

2021 2022
Net sales 5.06M 4.42M 4.08M 3.78M 7.17M 483M 7.29M 48.86M 19.16M 237M 18.99M 18.58M 821M 4.42M 3.87M 3.57M 3.3M 6.26M 422M 6.37M 42.7M 16.74M 207M 16.59M 16.23M 718M
Net income -14.76M -12.91M -11.91M -11.02M -20.91M -1.41B -21.26M -143M -55.89M -692M -55.4M -54.2M -2.4B -13.52M -11.83M -10.91M -10.09M -19.16M -1.29B -19.48M -131M -51.21M -634M -50.76M -49.66M -2.2B
Net Debt 2.41M 2.11M 1.94M 1.8M 3.41M 230M 3.47M 23.26M 9.12M 113M 9.04M 8.84M 391M 1.8M 1.57M 1.45M 1.34M 2.55M 172M 2.59M 17.36M 6.81M 84.23M 6.75M 6.6M 292M
Logo G MEDPAR
G Medical Innovations Holdings Ltd. is a mobile health (mHealth) and e-health company. The Company is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. It also develops wireless vital signs monitoring systems.
Employees
84
Sector
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. GMVDF Stock